Patent EP4507726A1: Arginine formulations with PD-1 antibody
Summary
Patent EP4507726A1: Arginine formulations with PD-1 antibody
Source document (simplified)
STABLE HIGH CONCENTRATION ARGININE FORMULATIONS CONTAINING PD-1 ANTIBODY AND METHODS OF USE THEREOF
Publication EP4507726A1 Kind: A1 Mar 18, 2026
Applicants
BeiGene Switzerland GmbH
Inventors
JIN, Xiaoqing, JI, Yu, GU, Sufang, SHEN, Jian, QIU, Bo, WU, Jun
IPC Classifications
A61K 39/395 20060101AFI20231020BHEP A61K 39/00 20060101ALI20231020BHEP C07K 16/18 20060101ALI20231020BHEP A61K 47/26 20060101ALI20231020BHEP C07K 14/705 20060101ALI20231020BHEP C07K 16/00 20060101ALI20231020BHEP A61P 35/00 20060101ALI20231020BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.